Savara Inc.
$5.13
-$0.13 (-2.47%)
$5.11Day Range$5.35
Key Statistics
Market Cap
$1.08B
Shares Outstanding
205.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 18, 1996
Round Lot
100
Locale
US
Trading Data
Day Open
$5.29
Day High
$5.35
Day Low
$5.11
Volume
1.13M
VWAP
$5.20
Prev Close
$5.26
Transactions
--
Acc. Volume
--
About Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
PHARMACEUTICAL PREPARATIONSSIC 283470 employees6836 BEE CAVE ROAD, AUSTIN, TX, 7874651285113796IPO Nov 18, 1996US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001160308
- Composite FIGI
- BBG000MS0823
- Share Class FIGI
- BBG001SFTVM9
- Ticker Root
- SVRA
- SIC Code
- 2834
About Savara Inc. (SVRA) Stock
Savara Inc. (SVRA) closed the 2026-09-16 session at $5.13, down 2.47% versus the previous close (-0.13). The stock opened at $5.29 and traded between $5.11 and $5.35 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $5.20.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Savara Inc. has a market capitalization of $1.08 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SVRA is listed on the XNAS exchange. The company employs approximately 70 people. Savara Inc. is headquartered in AUSTIN, TX. The recorded listing date is 1996-11-18.
On this page you can find market SVRA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.